Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$63,959,296
+$3,258,245 QoQ
Shares Held
251,838
+1.4% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
1.20%
of 13F equity value
Holder Rank
#396
of 4,676 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Horizon Investments, LLC holds $251,395,826 across 12 Drug Manufacturers - General names. JNJ ranks #2 (25.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
57,355 | $68,793,313 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
251,838 | $63,959,296 | |
| 3 | MRK |
Merck & Co., Inc.
|
291,282 | $37,429,737 | |
| 4 | ABBV |
AbbVie Inc.
|
103,457 | $26,033,919 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
149,785 | $18,923,836 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
251,893 | $14,514,074 | |
| 7 | AMGN |
Amgen Inc
|
35,484 | $12,849,466 | |
| 8 | PFE |
Pfizer Inc
|
193,281 | $4,654,206 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $63,959,296 | 251,838 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $60,701,051 | 248,327 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $47,064,569 | 227,420 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $43,588,719 | 235,081 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $22,239,789 | 145,596 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,617,483 | 27,843 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $3,706,176 | 25,627 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $3,770,487 | 23,266 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,873,186 | 12,816 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $6,333,927 | 40,040 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $7,386,059 | 47,123 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $7,709,313 | 49,498 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $8,717,110 | 52,665 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,536,100 | 48,620 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $10,615,428 | 60,093 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $7,496,100 | 45,887 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,606,212 | 37,216 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $11,833,115 | 66,767 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $4,885,759 | 28,560 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $13,128,012 | 81,288 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $12,021,901 | 72,975 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $7,135,090 | 43,414 | Shares | Sole | 2021-05-14 | |
| 2020-09-30 | $8,586,058 | 57,671 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $10,582,548 | 75,251 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $6,964,838 | 53,114 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||